Action

FGFR

Alt Name

Approval Jurisdiction

2020 FDA

Approved for clinical use

Cholangiocarcinoma with FGFR2 fusion 

Brutto

CAS

1513857-77-6

Commercial Vendor

Incyte

Compound Image

Pemigatinib.png

Compound name

Pemigatinib

InChI

InChI=1S/C24H27F2N5O4/c1-4-30-21-14(11-27-23-16(21)9-15(28-23)13-29-5-7-35-8-6-29)12-31(24(30)32)22-19(25)17(33-2)10-18(34-3)20(22)26/h9-11H,4-8,12-13H2,1-3H3,(H,27,28)

InChI Key

HCDMJFOHIXMBOV-UHFFFAOYSA-N

MW

487.50

PubChem CID

86705695

Reference

Reference 2

SMILES

CCN1C2=C3C=C(NC3=NC=C2CN(C1=O)C4=C(C(=CC(=C4F)OC)OC)F)CN5CCOCC5

Approved Drug List

1